A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection

Canadian Journal of Microbiology

Volumn 44, Issue 3, 1998, Pages 201-210

  Fallone, Carlo A ^a,b   Barkun, Alan N ^a   Göttke, Markus U ^a   Beech, Robin N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Bacterial; Genetics; Helicobacter pylori; Virulence

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CYTOTOXIN; UREASE; VIRULENCE FACTOR;

BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; ENVIRONMENTAL FACTOR; FLAGELLUM; GENE SEQUENCE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

DISEASE SUSCEPTIBILITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; VIRULENCE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0031864030     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjm-44-3-201     Document Type: Review

References (119)

1. Akopyanz, N., Bukanov, N.O., Westblom, T.U., Kresovich, S., and Berg, D.E. 1992. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD finger printing. Nucleic Acids Res. 20: 5137-5142.
2. Alkout, A.M., Blackwell, C.C., Weir, D.M., Poxton, I.R., Elton, R.A., Luman, W., and Palmer, K. 1997. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis (a) and Lewis (b) antigens. Gastroenterology, 112: 1179-1187.
3. Atherton, J.C., Cao, P., Peek, R.M., Jr., Tummuru, M.K., Blaser, M.J., and Cover, T.L. 1995.Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270: 17771-17777.
4. Atherton, J.C., Tham, K.T., Peek, R.M., Jr., Cover, T.L., and Blaser, M.J. 1996. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 174: 552-556.
5. Atherton, J.C., Peek, R.M., Jr., Tham, K.T., Cover, T.L., and Blaser, M.J. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology, 112: 92-99.
6. Bateson, M.C. 1993. Cigarette smoking and Helicobacter pylori infection. Postgrad. Med. J. 69: 41-44.
7. Beech, R.N., Goettke, M.U., Groody, J.M., Loo, V., Fallone, C.A., and Barkun, A.N. 1996. Utility of vacA DNA as a genetic marker for virulence in Helicobacter pylori. Gastroenterology, 110: Abstr. A63.
8. Blaser, M.J. 1994. Helicobacter pylori phenotypes associated with peptic ulceration. Scand. J. Gastroenterol. 29(Suppl. 205): 1-5.
9. Blaser, M.J., Perez-Perez, G.I., Kleanthous, H., Cover, T.L., Peek, R.M., Chyou, P.H., Stemmermann, G.N., and Nomura, A. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55: 2111-2115.
10. Boren, T., Falk, P., Roth, K.A., Larson, G., and Normark, S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science (Washington, D.C.), 262: 1892-1895.
11. Boren, T., Normark, S., and Falk, P. 1994. Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol. 2: 221-228.
12. Censini, S., Lange, C., Xiang, Z.Y., Crabtree, J.E., Ghiara, P., Borodovsky, M., Rappuoli, R., and Covacci, A. 1996. Cag, a pathogenicity island of Helicobacter pylori, encodes type I specific and disease associated virulence factors. Proc. Natl. Acad. Sci. U.S.A. 93: 14648-14653.
13. Ching, C.K., Wong, C.Y., Kwok, E., Ong, L., Covacci, A., and Lam, S.K. 1996. Prevalence of cagA-bearing Helicobacter pylori strains detected by the anti-cagA assay in patients with peptic ulcer disease and in controls. Am. J. Gastroenterol. 91: 949-953.
14. Chittajallu, R.S., Neithercut, W.D., Ardill, E.S., and McColl, K.E.L. 1992. Helicobacter pylori-related hypergastrinemia is not due to elevated antral surface pH studies with antral alkalinisation. Scand. J. Gastroenterol. 27: 218-222.
15. Chiverton, S.G., and Hunt, R.H. 1989. Smoking and duodenal ulcer disease. J. Clin. Gastroenterol. 11(Suppl. 1): S29-S33.
16. Clyne, M., and Drumm, B. 1997. Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology, 113: 72-80.
17. Correa, P., Fontham, E., Pickle, L.W., Chen, V., Lin, Y.P., and Haenszel, W. 1985. Dietary determinants of gastric cancer in south Louisiana inhabitants. J. Natl. Cancer Inst. 75: 645-654.
18. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., and Rappuoli, R. 1993. Molecular characterisation of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U.S.A. 90: 5791-5795.
19. Cover, T.L., Dooley, C.P., and Blaser, M.J. 1990. Characterization of and human serologicresponse to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58: 603-610.
20. Cover, T.L., Cao, P., Lind, C.D., Tham, K.T., and Blaser, M.J. 1993. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect. Immun. 61: 5008-5012.
21. Cover, T.L., Tummuru, M.K., Cao, P., Thompson, S.A., and Blaser, M.J. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269: 10566-10573.
22. Crabtree, J.E., Taylor, J.D., Wyatt, J.I., Heatley, R.V., Shallcross. T.M., Tompkins, D.S., and Rathbone, B.J. 1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet, 338: 332-335.
23. Cryer, B., Lee, B., and Feldman, M. 1992. Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging. Ann. Intern. Med. 116: 636-640.
24. Cuello, C., Correa, P., Haenszel, W., Gordillo, G., Brown, C., Archer, M., and Tannenbaum, S. 1976. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J. Natl. Cancer Inst. 57: 1015-1020.
25. Cullen, D.J.E., Collins, B.J., Christiansen, K.J., Epis, J., Warren, J.R., and Cullen, K.J. 1993. Long term risk of peptic ulcer disease in people with Helicobacter pylori infection - a community based study. Gastroenterology, 104: Abstract A60.
26. Desai, M., Linton, D., Owen, R.J., and Stanley, J. 1994. Molecular typing of Helicobacter pylori isolates from asymptomatic, ulcer and gastritis patients by urease gene polymorphism. Epidemiol. Infect. 112: 151-160.
27. Dooley, C.P., Cohen, H., Fitzgibbons, P.L., Bauer, M., Appleman, M.D., Perez-Perez, G.I., and Blaser, M.J. 1989. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N. Engl. J. Med. 321: 1562-1566.
28. Dorant, E., Van der Brandt, P.A., Goldbohm, R.A., and Sturmans, F. 1996. Consumption of onions and a reduced risk of stomach cancer. Gastroenterology, 110: 12-20.
29. Dubois, A., Berg, D.E., Incecik, E.T., Fiala, N., Heman-Ackah, L.M., Perez-Perez, G.I., and Blaser, M.J. 1996. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64: 2885-2891.
30. Eaton, K.A., and Krakowka, S. 1994. Effect of gastric pH on urease-dependent colonization ofgnotobiotic piglets by Helicobacter pylori. Infect. Immun. 62: 3604-3607.
31. Eaton, K.A., Brooks, C.L., Morgan, D.R., and Krakowka, S. 1991. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59: 2470-2475.
32. Eurogast Study Group. 1993. An international association between Helicobacter pylori and gastric cancer. Lancet, 341: 1359-1362.
33. Evans, D.G., Evans, D.J., Jr., Moulds, J.J., and Graham, D.Y. 1988. N-Acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a pictative colonization factor antigens. Infect. Immun. 56: 2896-2906.
34. Evans, D.G., Evans, D.J., Jr., Takemura, T., Nakano, H., Lampert, H.C., Graham, D.Y., Granger, D.N., and Kvietys, P.R. 1995. Characterization of Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63: 2213-2220.
35. Faller, G., Steininger, H., Eck, M., Hensen, J., Hahn, E.G., and Kirchner, T. 1996. Antigastricautoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch. 427: 483-486.
36. Figura, N., Guglienetti, P., Rossolini, A., Barberi, A., Cusi, G., Musmanno, R.A., Russi, M., and Quaranta, S. 1989. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J. Clin. Microbiol. 27: 225-226.
37. Forbes, K.J., Fang, Z., and Pennington, T.H. 1995. Allelic variation in the Helicobacter pylori flagellin genes flaA and flaB: its consequences for strain typing schemes and population structure. Epidemiol. Infect. 114: 257-266.
38. Ghiara, P., Marchetti, M., Blaser, M.J., Tummuru, M.K., Cover, T.L., Segal, E.D., Tompkins, L.S., and Rappuoli, R. 1995. Role of the Helicobacter pylori virulence factors vacuolatingcytotoxin, cagA and urease in a mouse model of disease. Infect. Immun. 63: 4154-4160.
39. Go, M.F., and Graham, D.Y. 1996. Prevalence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or assymptomatic gastritis. Helicobacter, 1: 107-111.
40. Go, M.F., Kapur, V., Graham, D., and Musser, J.M. 1996. Population genetic analysis of H. pylori by multilocus enzyme electrophoresis: extensive allele diversity and recombinational population structure. J. Bacteriol. 178: 3934-3938.
41. Goggin, P.M., Collins, D.A., Jazrawi, R.P., Jackson, P.A., Corbishley, C.M., Bourke, B.E., and Northfield, T.C. 1993. Prevalence of Helicobacter pylori infection and its effect on symptoms and nonsteroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut, 34: 1677-1680.
42. Graham, D.Y., Adam, E., Reddy, G.T., Agarwal, J.P., Agarwal, R., Evans, D.J., Jr., Malaty, H.M., and Evans, D.G. 1991a. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig. Dis. Sci. 36: 1084-1088.
43. Graham, D.Y., Lidsky, M.D., Cox, A.M., Evans, D.J., Jr., Evans, D.G., Alpert, L., Klein, P.D., Sessoms, S.L., Michaletz, P.A., and Saeed, Z.A. 1991b. Long-term nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology, 100: 1653-1657.
44. Graham, D.Y., Malaty, H.M., and Go, M.F. 1994. Are there susceptible hosts to Helicobacterpylori infection? Scand. J. Gastroenterol. 29(Suppl. 205): 6-10.
45. Gubbins, G.P., Shubert, T.T., Attanasio, F., Lubetsky, M., Perez-Perez, G.I., and Blaser, M.J. 1992. Helicobacter pylori seroprevalence in patients with rheumatoid arthritis: effect of nonsteroidal anti-inflammatory drugs and gold compounds. Am. J. Med. 93: 412-418.
46. Harris, P.R., Mobley, H.L.T., Perez-Perez, G.I., Blaser, M.J., and Smith, P.D. 1996. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology, 111: 419-425.
47. Heresbach, D., Raoul, J.L., Bretagne, J.F., Minet, J., Donnio, P.Y., Ramee, M.P., Siproudhis, L., and Gosselin, M. 1992. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Gut, 33: 1608-1611.
48. Hurtado, A., Chahal, B., Owen, R.J., and Smith, A.W. 1994a. Genetic diversity of the Helicobacter pylori haemagglutinin/protease (hap) gene. FEMS Microbiol. Lett. 123: 173-178.
49. Hurtado, A., Owen, R.J., and Desai, M. 1994b. Flagellin gene profiling of Helicobacter pylori infecting symptomatic and asymptomatic individuals. Res. Microbiol. 145: 585-594.
50. Janssen, M., Dijkmans, B.A., Lamers, C.B., Zwinderman, A.H., and Vandenbroucke, J.P. 1994. A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients. Br. J. Rheumatol. 33: 449-454.
51. Jiang, Q., Hiratsuka, K., and Taylor, DE. 1996. Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol. Microbiol. 20: 833-842.
52. Jones, S.T., Clague, R.B., Eldridge, J., and Jones, D.M. 1991. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br. J. Rheumatol. 30: 16-20.
53. Josenhans, C., Labigne, A., and Suerbaun, S. 1995. Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J. Bacteriol. 177: 3010-3020.
54. Kansau, I., and Labigne, A. 1996. Heat shock proteins of Helicobacter pylori. Aliment. Pharmacol. Ther. 10(Suppl. 1): 51-56.
55. Kelly, S.M., Crampton, J.R., and Hunter, T.O. 1993. Helicobacter pylori increases gastric antral juxtamucosal pH. Dig. Dis. Sci. 38: 129-131.
56. Knipp, V., Birkholz, S., Kaup, W., and Opferkuch, W. 1993. Immune suppressive effects of Helicobactor pylori on human peripheral blood mononuclear cells. Med. Microbiol. Immunol. 182: 63-76.
57. Kostrzynska, M., O'Toole, P.W., Taylor, D.E., and Trust, T.J. 1994. Molecular characterization of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori. J. Bacteriol. 176: 5938-5948.
58. Labigne, A., and de Reuse, H. 1996. Determinants of Helicobacter pylori pathogenicity. Infect. Agents Dis. 5: 191-202.
59. Lee, A., Fox, J., and Hazell, S. 1993. Pathogenicity of Helicobacter pylori: a perspective. Infect. Immun. 61: 1601-1610.
60. Leoci, C., Ierardi, E., Chiloiro, M., Piccioli, E., Di Matteo, G., Misciagna, G., and Giorgio, I. 1995. Incidence and risk factors of duodenal ulcer: a retrospective cohort study. J. Clin. Gastro- enterol. 20: 104-109.
61. Leunk, R.D. 1991. Production of a cytotoxin by Helicobacter pylori. Rev. Infect. Dis. 13: S686-S689.
62. Lingwood, C.A., Law, H., Pellizzari, A., Sherman, P., and Drumm, B. 1989. Gastrric glycerlipid as a receptor for Campylobacter pylori. Lancet, 11: 238-241.
63. Logan, R.P.H. 1996. Adherence of Helicobacter pylori. Aliment. Pharmacol. Ther. 10(Suppl. 1): 3-15.
64. Lopez, C.R., Owen, R.J., and Desai, M. 1993. Differentiation between isolates of Helicobacter pylori by PCR-RFLP analysis of urease A and B genes and comparison with ribosomal RNA gene patterns. FEMS Microbiol. Lett. 110: 37-43.
65. Macchia, G., Massone, A., Burroni, D., Covacci, A., Censini, S., and Rappuoli, R. 1993. The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases. Mol. Microbiol. 9: 645-652.
66. Malaty, H.M., Engstrand, L., Pederson, N.L., and Graham, D.Y. 1994. Helicobacter pylori infection: genetic and environmental influences: a study of twins. Ann. Intern. Med. 120: 982-986.
67. Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappuoli, R., and Ghiara, P. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (Washington, D.C.), 267: 1655-1658.
68. Marshall, B.J. 1994. Helicobacter pylori. Am. J. Gastroenterol, 89: S116-S128.
69. McGowan, C.C., Cover, T.L., and Blaser, M.J. 1996. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology, 110: 926-938.
70. Megraud, F., Brassens-Rabbe, M.P., Denis, F., Belbouri, A., and Hao, D.Q. 1989. Seroepidemiology of Campylobacter pylori infection in various populations. J. Clin. Microbiol. 27: 1870-1873.
71. Miehlke, S., Kibler, K., Kim, J.G., Figura, N., Small, S.M., Graham, D.Y., and Go, M.F. 1996. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am. J. Gastroenterol. 91: 1322-1325.
72. Moran, A.P. 1995. Cell surface characteristics of Helicobacter pylori. FEMS Microbiol. Immunol. 10: 271-280.
73. Moran, A.P. 1996. Pathogenic properties of Helicobacter pylori. Scand. J. Gastroenterol. 31(Suppl. 215): 22-31.
74. Murakita, H., Hirai, M., Ito, S., Azuma, T., Kato, T., and Kohli, Y. 1994. Vacuolation cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients. Eur. J. Gastroenterol. Hepatol. 6: S29-S31.
75. Nazario, C.M., Szklo, M., Diamond, E., Roman-Franco, A., Climent, C., Suarez, E., and Conde, J.G. 1993. Salt and gastric cancer: a case-control study in Puerto Rico. Int. J. Epidemiol. 22: 790-797.
76. Negrini, R., Lisato, L., Zannella, I., Cavazzini, L., Gullini, S., Villanacci, V., Poiesi, C., Albertini, A., and Ghielmi, S. 1991. Helicobacter pylori infection induces antibodies crossreacting with human gastric mucosa. Gastroenterology, 101: 437-445.
77. Negrini, R., Savio, A., Poiesi, C., Appelmelh, B.J., Buffoli, F., Paterlini, A., Cesari, P., Graffeo, M., Vaira, D., and Franzin, G. 1996. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology, 111: 655-665.
78. Nilius, M., and Malfertheiner, P. 1996. Helicobacter pylori enzymes. Aliment. Pharmacol. Ther. 10: 65-71.
79. Nomura, A., Yamakawa, H., Ishidate, T., Kamiyama, S., Masuda, H., Stemmermann, G.N., Heilburn, L.K., and Hankin, J.H. 1982. Intestinal metaplasia in Japan: association with diet. J. Natl. Cancer. Inst. 68: 401-405.
80. Owen, R.J., Bickley, J., Costas, M., and Morgan, D.R. 1991. Genomic variation in Helicobacter pylori: application to identification of strains. Scand. J. Gastroenterol. 181: 43-50.
81. Owen, R.J., Hurtado, A., Benatvala, N., Abdi, Y., Davies, G.R., Feldman, R., and Hardie, J.M. 1994. Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol. Med. Microbiol. 9: 307-315.
82. Patchett, S.E., Katelaris, P.H., Lin, L., Wilks, M., Zhang, Z.W., Domizio, P., Farthing, M.J.G., and Tabaqchali, S. 1995. CagA expression in Helicobacter pylori related gastroduodenal disease. Gastroenterology, 108: Abstr. A187.
83. Peek, R.M., Thompson, S.A., Atherton, J.C., Blaser, M.J., and Miller, G.G. 1996. Expression of a novel ulcer-associated H. pylori gene, iceA, following adherence to gastric epithelial cells. Gastroenterology, 110: Abstr. A225.
84. Perez-Perez, G.I., and Blaser, M.J. 1987. Conservation and diversity of Campylobacter pyloridis major antigens. Infect. Immun. 55: 1256-1263.
85. Plotrowski, J., Morita, M., Slomiany, A., and Slomiany, B.L. 1992. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Effect of ebrotidine. Biochem Int. 271: 131-138.
86. Prewett, E.J., Bickley, J., Owen, R.J., and Pounder, R.E. 1992. DNA pattern of Helicobacter pylori isolated from gastric antrum, body and duodenum. Gastroenteroloy, 102: 829-833.
87. Pugliese, G., Sanseverino, P., De Giuli, M., Margaria, E., Soldati, T., Valente, G., De Marco, L., Perotto, C., Parello, G., Morgando, A., Cassarino, E., Marchiaro, G., Fronda, G.R., Verme, G., and Ponzetto, A. 1995. CagA positive Helicobacter pylori infection is found in 96% of gastric cancer cases of Italian patients. Gastroenterology, 108: Abstr. A196.
88. Rautelin, H., Blomberg, B., Fredlund, H., Järnerot, G., and Danielsson, D. 1993. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut, 34: 599-603.
89. Rautelin, H., Blomberg, B., Järnerot, G., and Danielsson, D. 1994. Non-opsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand. J. Gastroenterol, 29: 128-132.
90. Ricci, V., Ciacci, C., Zarrilli, R., Samni, P., Tummuru, M.K., Del Vecchio Blanco, C., Bruni, C.B., Cover, T.L., Blaser, M.J., and Romano, M. 1996. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of vacA and cagA. Infect. Immun. 64: 2829-2833.
91. Schmitt, W., and Haas, R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12: 307-319.
92. Segal, E.D., Falkon, S., and Tompkins, L.S. 1996. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phorphorylation of host cell proteins. Proc. Natl. Acad. Sci. U.S.A. 93: 1259-1264.
93. Sherbourne, R., and Taylor, D.E. 1995. Helicobacter pylori expresses a complex surface carbohydrate, Lewis X. Infect. Immun. 63: 4564-4568.
94. Sipponen, P., Varis, K., Fräki, O., Korri, U.M., Seppälä, K., and Siurala, M. 1990. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand. J. Gastroenterol. 25: 966-973.
95. Sjostrom, J.E., and Larsson, H. 1996. Factors affecting growth and antbiotic susceptibility of Helicobactor pylori: effect of pH and urea on the survival of a wild type strain and a urease deficient mutant. J. Med. Microbiol.44: 425-33.
96. Solnick, J.V., and Tompkins, L.S. 1993. Helicobacter pylori and gastroduodenal disease: pathogenesis and host-parasite interaction. Infect. Agents Dis. 1: 294-309.
97. Taha, A.S., Sturrock, R.D., and Russell, R.I. 1995. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut, 36: 334-336.
98. Takami, S., Hayashi, T., Tonokatso, Y., Shimoyama, T., and Tamura, T. 1993. Chromosomal heterogeneity of Helicobacter pylori isolates by pulsed-field gel electrophoresis. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 280: 120-127.
99. Tanaka, N., Kuwayama, H., and Nakajima, M. 1993. Digestion of human gastric mucous by extracellular Helicobacter pylori enzyme. Nippon Rinsho, 51: 3163-3165.
100. Taylor, D.E. 1992. Genetics of Camylobacter and Helicobacter. Annu. Rev. Microbiol. 46: 35-64.
101. Taylor, D.E., Featon, M., Chang, N., and Salama, S.M. 1992. Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J. Bacteriol. 174: 6800-6806.
102. Tee, W., Lambert, J.R., and Dwyer, B. 1995. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J. Clin. Microbiol. 33: 1203-1205.
103. Telford, J.L., Ghiara, P., Dell'Orco, M., Comanducci, M., Burroni, D., Bugnoli, M., Teece, M.F., Censini, S., Covacci, A., and Xiang, Z. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its role in gastric disease. J. Exp. Med. 179: 1653-1658.
104. Thillainayagam, A.V., Tabaqchali, S., Warrington, S.J., and Farthing, M.J. 1994. Interrelationships between Helicobacter pylori in- fection, nonsteroidal antiinflammatory drugs and gastroduodenal disease: a prospective study in healthy volunteers. Dig. Dis. Sci. 39: 1085-1089.
105. Tomb, J.F., White, O., Kerlavage, A.R., Clayton, R.A., Sutton, G.G., Fleischmann, R.D., Ketchum, K.A., Klenk, H.P., Gill, S., Dougherty, B.A., Nelson, K., Quackenbush, J., Zhou, L., Kirkness, E.F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H.G., Glodek, A., McKenney, K., Fitzgerald, L.M., Lee, N., Adams, M.D., Hickey, E.K., Berg, D.E., Gocayne, J.D., Utterback, T.R., Peterson, J.D., Kelley, J.M., Cotton, M.D., Weldman, J.M., Fujii, C., Bowman, C., Wattney, L., Wallin, E., Hayes, W.S., Borodovsky, M., Karp, P.D., Smith, H.O., Fraser, C.M., and Venter, J.C. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (London), 388: 539-547.
106. Tsuda, M., Hkarita, M., Mizote, T., Morshed, M.G., Okita, K., and Nakazawa, T. 1994. Essential role of Helicobacter pylori urease in gastric colonization: definite proof using a urease-negative mutant constructed by gene replacement. Eur. J. Gastroenterol. Hepatol. 6: S49-S52.
107. Tsugane, S., Tei, Y., Takahashi, T., Watanabe, S., and Sugano, K. 1994. Salty food intake and risk of Helicobacter pylori infection. Jpn. J. Cancer. Res. 85: 474-478.
108. Tummuru, M.K., Cover, T.L., and Blaser, M.J. 1993. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61: 1799-1809.
109. Tummuru, M.K., Cover, T.L., and Blaser, M.J. 1994. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62: 2609-2613.
110. Tummuru, M.K., Sharma, S.A., and Blaser, M.J. 1995. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastricepethelial cells. Mol. Microbiol. 18: 867-876.
111. Vollmers, H.P., Dämmrich, J., Ribbert, H., Grassel, S., Debus, S., Heesemannn, J., and Müller-Hermelink, H.K. 1994. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer, 74: 1525-1532.
112. Wadström, T., Guruge, J., Wel, S., Aleijung, P., and Ljungh, A. 1990. Helicobacter pylori hemagglutinins - possible gut mucosa adesions. In Helicobacter pylori, gastritis and peptic ulcer. Edited by P. Malfertheiner and H. Ditschuneit. Springer-Verlag, Berlin, pp. 96-103.
113. Weel, J.F.L., van der Hulst, R.W., Gerrits, Y., Roorda, P., Feller, M., Dankert, J., Tytgat, G.N., and van der Ende, A. 1996. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J. Infect. Dis. 173: 1171-1175.
114. Wotherspoon, A.C., Ortiz-Hidalgo, C., Falzon, M.R., and Isaacson, P.G. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338: 1175-1176.
115. Xiang, Z., Censini, S., Bayeli, P.F., Telford, J.L., Figura, N., Rappvoli, R., and Covacci, A. 1995. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63: 94-98.
116. Yamaguchi, H., Osaki, T., Taguchi, H., Hanawa, T., Yamamoto, T., and Kamiya, S. 1996. Flow cytometric analysis of the heat shock protein 60 expressed on the cell surface of Helicobacter pylori. J. Med. Microbiol. 45: 270-277.
117. You, W.C., Blot, W.J., Chang, Y.S., Ershow, A.G., Yang, Z.T., An, Q., Henderson, B., Xu, G.W., Fraumeni, J.F., Jr., and Wang, T.G. 1988. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 48: 3518-3523.
118. Zhang, Q.B., Nakshabendi, I.M., Mokhashi, M.S., Dawoder, J.B., Gemmell, C.G., and Russell, R.I. 1996. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut, 38: 841-845.
119. Zhou, D.Y., Yang, H.T., and Song, M. 1995. Serum cagA IgG antibodies in Chinese patients with gastritis and duodenal ulcer. Gastroenterology, 108: Abstr. A267.